Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in …
…, AS Semikhin, YV Simakova, EA Tokarskaya… - The Lancet, 2021 - thelancet.com
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1 …
…, AS Semikhin, YV Simakova, EA Tokarskaya… - The Lancet, 2020 - thelancet.com
Background We developed a heterologous COVID-19 vaccine consisting of two components,
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
[HTML][HTML] An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus …
…, YV Simakova, EA Tokarskaya… - The Lancet Regional …, 2021 - thelancet.com
Background While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
Sputnik V effectiveness against hospitalization with COVID-19 during Omicron dominance
…, IP Lupu, RR Adgamov, AP Tkachuk, EA Tokarskaya… - Vaccines, 2022 - mdpi.com
Mass vaccination campaigns against COVID-19 affected more than 90% of the population
in most developed countries. The new epidemiologic wave of COVID-19 has been ongoing …
in most developed countries. The new epidemiologic wave of COVID-19 has been ongoing …
One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the …
…, TA Ozharovskaya, AS Semikhin, EA Tokarskaya… - medRxiv, 2021 - medrxiv.org
Objectives Vaccination remains the most effective response to the COVID-19 pandemic. Most
vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, …
vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, …
An open, non-randomised, 1/2 phase study on the safety, tolerability, and immunogenicity of single dose'Sputnik light'vaccine for prevention of coronavirus infection in …
…, AS Semikhin, YV Simakova, EA Tokarskaya… - 2021 - papers.ssrn.com
Background: While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by obvious shortage in supply of licensed vaccines. …
vaccination program is hampered by obvious shortage in supply of licensed vaccines. …
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label …
…, IB Esmagambetov, EA Tokarskaya… - Frontiers in …, 2023 - frontiersin.org
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label,
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
Educational potential of visual novels in remedial and developmental work
LV Tokarskaya, TY Bystrova, EA Osnovina… - 2023 - elar.urfu.ru
Introduction. The relevance of the presented problems is due to the need to find modern
resources for teaching children with disabilities. The work reveals the features of visual novels …
resources for teaching children with disabilities. The work reveals the features of visual novels …
Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease A …
JM Figueroa, M Lombardo, A Dogliotti, LP Flynn… - medRxiv, 2021 - medrxiv.org
Background Iota-Carrageenan (IC) is a sulfate polysaccharide synthesized by red algae,
with demonstrated antiviral activity and clinical efficacy as nasal spray in the treatment of …
with demonstrated antiviral activity and clinical efficacy as nasal spray in the treatment of …
Increased level of chromosomal aberrations in lymphocytes of Chernobyl liquidators 6–10 years after the accident
N Slozina, E Neronova, T Kharchenko… - … Molecular Mechanisms of …, 1997 - Elsevier
Chromosomal aberrations (CA) were used to investigate the level of cytogenetical damage
in peripheral blood lymphocytes from the liquidators in a remote period (6–10 years) after the …
in peripheral blood lymphocytes from the liquidators in a remote period (6–10 years) after the …
